Edition:
India

People: Bio Rad Laboratories Inc (BIO.N)

BIO.N on New York Stock Exchange

376.89USD
17 Jan 2020
Change (% chg)

$-2.81 (-0.74%)
Prev Close
$379.70
Open
$380.13
Day's High
$380.39
Day's Low
$375.58
Volume
143,299
Avg. Vol
66,221
52-wk High
$391.22
52-wk Low
$233.21

Edwards, Jeffrey 

Mr. Jeffrey L. Edwards serves as Independent Director of the Company. Mr. Edwards retired from Allergan, Inc., a multi-specialty health care company, in February 2015 after nearly 22 years at Allergan. From September 2005 to August 2014, he served as Executive Vice President, Finance and Business Development, Chief Financial Officer at Allergan. From 2003 to 2005 he served as Allergan’s Corporate Vice President, Corporate Development and previously served as Senior Vice President, Treasury, Tax and Investor Relations. Prior to joining Allergan, Mr. Edwards was with Banque Paribas from 1992-1993 and Security Pacific National Bank from 1983-1992, where he held various senior-level positions in the credit and business development functions. Mr. Edwards currently serves on the Board of Directors and as Audit Committee chairman of FibroGen, Inc., a publicly traded biopharmaceutical company, and on the Board of Directors and the Compensation Committee of Clearside Biomedical, Inc., a publicly traded development stage pharmaceutical company. Mr. Edwards has over 25 years of public company experience. We believe that Mr. Edwards’ deep financial, capital allocation, and business development experience give him the qualifications and skills to serve as a director.

Basic Compensation

Total Annual Compensation, USD 140,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 140,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --